GLAUKOS Corp Research and Development in Process
GLAUKOS Corp (GKOS) reported Research and Development in Process of $10.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-02-24
- GLAUKOS Corp research and development in process for the quarter ending 2022-12-31 was $0.00.
- GLAUKOS Corp research and development in process for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- GLAUKOS Corp research and development in process for the quarter ending 2022-06-30 was $10.00M, a 100.00% increase year-over-year.
- GLAUKOS Corp research and development in process for the quarter ending 2022-03-31 was $0.00.
- GLAUKOS Corp research and development in process for fiscal 2022 was $10.00M, a 0.00% change from fiscal 2021.
- GLAUKOS Corp research and development in process for fiscal 2021 was $10.00M.
- GLAUKOS Corp research and development in process for fiscal 2019 was $3.75M.
- GLAUKOS Corp research and development in process for fiscal 2017 was $5.32M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $10.00M derived: sum of 3 quarters · filed 2023-02-24 | $10.00M 10-K · filed 2023-02-24 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $10.00M derived: sum of 2 quarters · filed 2023-02-24 | $10.00M 10-Q · filed 2022-11-04 | $10.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2022-06-30 | $10.00M 10-K · filed 2023-02-24 | $10.00M 10-Q · filed 2022-08-05 | $10.00M derived: sum of 3 quarters · filed 2023-02-24 | $15.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2022-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $5.00M derived: sum of 3 quarters · filed 2023-02-24 | $10.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $5.00M derived: sum of 2 quarters · filed 2023-02-24 | $10.00M derived: sum of 3 quarters · filed 2023-02-24 | $10.00M 10-K · filed 2023-02-24 |
| 2021-09-30 | $5.00M 10-K · filed 2023-02-24 | $10.00M derived: sum of 2 quarters · filed 2023-02-24 | $10.00M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $5.00M 10-K · filed 2023-02-24 | $5.00M 10-Q · filed 2022-08-05 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.50M derived: sum of 2 quarters · filed 2022-02-28 | $3.75M derived: sum of 3 quarters · filed 2022-02-28 | $3.75M 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.50M 10-K · filed 2021-03-01 | $3.75M derived: sum of 2 quarters · filed 2021-03-01 | $3.75M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $2.25M 10-K · filed 2021-03-01 | $2.25M 10-Q · filed 2020-08-07 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $5.32M derived: sum of 3 quarters · filed 2020-03-02 | $5.32M 10-K · filed 2020-03-02 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $5.32M derived: sum of 2 quarters · filed 2019-02-28 | $5.32M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $5.32M 10-K · filed 2019-02-28 | $5.32M 10-Q · filed 2018-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |